These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 3373517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential susceptibility of haemolysin-sensitized erythrocytes to complement-mediated cytotoxicity: a biological manifestation of the relationship between antibody availability and complement fixation.
    Bakács T, Ringwald G, Kimber I.
    J Clin Lab Immunol; 1989 Oct; 30(2):61-7. PubMed ID: 2641530
    [Abstract] [Full Text] [Related]

  • 4. Differences in the competitive capacity of monoclonal antibody sensitized human A and B erythrocytes in complement mediated cytotoxicity.
    Bakács T, Ringwald G, Tusnády G, Végh Z, Klein E.
    J Clin Lab Immunol; 1990 Aug; 32(4):167-75. PubMed ID: 1966933
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative comparison of direct and cold-target competition assay in monocyte- and complement-mediated lysis of sensitized erythrocytes.
    Bakács T, Tótpál K, Ringwald G, Klein E.
    Immunol Lett; 1987 Nov; 16(2):89-95. PubMed ID: 3428935
    [Abstract] [Full Text] [Related]

  • 10. Lysis of alloantibody-sensitized human erythrocytes by peripheral blood mononuclear cells: heterogeneity of effector populations.
    Kimber I, Moore M.
    J Clin Lab Immunol; 1981 Jan; 5(1):41-6. PubMed ID: 6260947
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suppression of cell-mediated tumor cell lysis and complement-induced cytotoxicity by trypan blue.
    Scornik JC, Ruiz P, Hoffman EM.
    J Immunol; 1979 Sep; 123(3):1278-84. PubMed ID: 469250
    [Abstract] [Full Text] [Related]

  • 14. The detection and identification of subpopulations of circulating human lymphocytes, monocytes and neutrophils capable of effecting a mitogen-induced cell-mediated cytotoxic reaction towards erythrocytes of various species.
    Cortens M, Sklar S, Richter M.
    Immunology; 1980 Nov; 41(3):623-34. PubMed ID: 7461704
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Monocyte-mediated antibody-dependent cell-mediated cytotoxicity and spontaneous cytotoxicity in normals and cancer patients as assayed by human erythrocyte lysis.
    Bernhard MI, Pace RC, Unger SW, Wanebo HJ.
    Cancer Res; 1983 Sep; 43(9):4504-10. PubMed ID: 6871879
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibody-dependent, cell-mediated cytotoxicity against human red blood cells: correlation of effector cell type with enzymatic alteration of the target cell surface.
    Yust I, Frisch B, Goldsher N.
    Eur J Immunol; 1980 Feb; 10(2):127-31. PubMed ID: 6768574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.